Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis, an infectious disease caused by the Leishmania parasite and transmitted by phlebotomine sandflies. CL is manifested as skin lesions, which typically evolve to ulcerative lesions and may last for months or even years, if not treated. Currently available treatments against CL involve the use of particularly toxic and overpriced drugs, which, among other things, require long times of administration and do not always lead to the complete recovery of the patient. The use of in silico technologies, as the Universal Immune System Simulator (UISS), may be helpful in finding new and potentially more effective drugs against CL. © 2022 IEEE.
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator
Crispino E.;Maleki A.;Di Salvatore V.;Russo G.;Pappalardo F.
2022-01-01
Abstract
Cutaneous leishmaniasis (CL) is the most common form of leishmaniasis, an infectious disease caused by the Leishmania parasite and transmitted by phlebotomine sandflies. CL is manifested as skin lesions, which typically evolve to ulcerative lesions and may last for months or even years, if not treated. Currently available treatments against CL involve the use of particularly toxic and overpriced drugs, which, among other things, require long times of administration and do not always lead to the complete recovery of the patient. The use of in silico technologies, as the Universal Immune System Simulator (UISS), may be helpful in finding new and potentially more effective drugs against CL. © 2022 IEEE.| File | Dimensione | Formato | |
|---|---|---|---|
|
Cutaneous_Leishmaniasis.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
404.5 kB
Formato
Adobe PDF
|
404.5 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
